Baseline expression profiles of human breast carcinomas

mRNA expression profiles for 106 primary breast carcinomas Samples included N=53 triple-negative breast carcinomas (TNBC) and N=53 non-TNBC (ER+/PR+) samples. Only breast cancer patients whose carcinomas did not express HER2 receptors were included. The non-TNBC and TNBC groups were well balanced with no significant differences in age (non-TNBC: mean = 49, range = 32-80 years; TNBC: mean = 52, range = 30-79 years) and stage.